123 Main Street, New York, NY 10001
Investor Relations
This section of the Co-Diagnostics InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing.
Please note: All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes. Co-Diagnosticsassumes no responsibility for the accuracy of this data and provides it for informational purposes only.
NASDAQCODX
| Beta | (0.82) |
|---|---|
| Shares Outstanding | 31.3M |
| Average Volume (10 days) | 80.8K |
| Qtrly Dividend (Ann. Yield) | -- (--) |
Analyst Views
| Current Mean Recommendation | Hold |
|---|
| Strong Buy | 0 | |
|---|---|---|
| Buy | 0 | |
| Hold | 1 | |
| Underperform | 0 | |
| Sell | 0 |
Recent Insider Transactions
Dwight Egan Chief Executive Officer | 138,333 Acquire May 23, 2024 |
|---|---|
Dwight Egan Chief Executive Officer | (42,008) Dispose May 23, 2024 |
Serbin Richard Director | 30,000 Acquire May 23, 2024 |
Murphy Ted Director | 30,000 Acquire May 23, 2024 |
Brian Lee Brown Chief Financial Officer | 113,334 Acquire May 23, 2024 |
